Hoy Los Ángeles: Información y orientación en español para pacientes de cáncer de páncreas surge en linea
Let’s Win is introduced to the Spanish-speaking residents of Los Angeles though an article in the Spanish newspaper Hoy.
The Pancreatic Cancer Collective Awards $7 Million in First-Round “New Therapies Challenge” Grants
The Pancreatic Cancer Collective–a collaboration of the Lustgarten Foundation and Stand Up To Cancer–has awarded $7 million in grants to new therapies teams.
Let’s Win! Pancreatic Cancer Unveils Spanish-Language Website To Connect Latinos With Pancreatic Cancer Information, Resources, And Community
Launched on World Pancreatic Cancer Day, the website aims to empower Latinos with resources and information to learn about the…
Lustgarten Foundation Advances Pancreatic Cancer Research Through Partnerships with the Opening of Two New Laboratories
The Lustgarten Foundation announces two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber Cancer Institute and Massachusetts Institute of Technology (MIT).
Let’s Win Receives Biden Cancer Initiative FIERCE Award
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”
Pancreatic Cancer Organizations Join in Mourning Aretha Franklin
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
Pancreatic Cancer Specialist Speaks on Disease that Killed Aretha Franklin
Let’s Win’s Dr. Allyson Ocean spoke to FiOS1 News (Lower Hudson Valley) about pancreatic cancer and the death of Aretha Franklin.
“No one else should be told go home and die”: A call for more pancreatic cancer research
Camille Moses traveled to Washington, D.C., with Julie Fleshman from PanCAN to urge Congress to provide more funding for pancreatic cancer research.
Genetic Sequencing of Advanced Pancreatic Cancer Enables Personalized Medicine
Dr. Brian Wolpin has found that about 1/3 of pancreatic cancer patients may benefit from genetic sequencing to determine treatment.
Organoids Accurately Predict Treatment Response of Pancreatic Cancer Patients
An international team of researchers led by Dr. David Tuveson has found that organoids can predict how pancreatic cancer patients will respond to different treatments.
